DiaSorin receives FDA clearance for LIAISON Aldosterone assay

DiaSorin, Inc., has received Food and Drug Administration (FDA) clearance for its LIAISON Aldosterone immunoassay. The assay,...

Abbott announces CE Mark for test to aid with diagnosis and monitoring of diabetes

Abbott has announced CE Marking for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test. In 2009, an international...

FDA approves Tarceva (erlotinib) tablets and Roche cobas EGFR Mutation Test for NSCLC

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Tarceva (erlotinib) tablets for the initial...